Casdin Capital, LLC Stoke Therapeutics, Inc. Transaction History

Casdin Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$17.19 - $26.1 $2.06 Million - $3.13 Million	-120,000 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$16.8 - $34.15 $168,000 - $341,500	-10,000 Reduced 7.69%	120,000 $2.75 Million
Q3 2019 Nov 12, 2019	BUY	$20.53 - $37.72 $923,850 - $1.7 Million	45,000 Added 52.94%	130,000 $2.79 Billion
Q2 2019 Aug 13, 2019	BUY	$25.53 - $29.17 $2.17 Million - $2.48 Million	85,000 New	85,000 $0

124

57.6M

9.3K

35.2K

Ticker STOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,419,300
Market Cap $445M
Description
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...

Get notified when there are updates to the investment portfolio of Casdin Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Casdin Capital, LLC with notifications on news.